California State Teachers Retirement System Phathom Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

$78.8 Billion
Q1 2025

A detailed history of California State Teachers Retirement System transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 35,262 shares of PHAT stock, worth $322,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,262

Previous 35,262 -0.0%

Holding current value

$322,647

Previous $286,000 22.73%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.45 - $18.94 $7 - $18	1 Added 0.0%	35,262 $286,000
Q3 2024 Apr 04, 2025	SELL	$10.25 - $19.5 $10 - $19	-1 Reduced -0.0%	35,261 $637,000
Q3 2024 Nov 14, 2024	BUY	$10.25 - $19.5 $63,652 - $121,095	6,210 Added 21.38%	35,261 $637,000
Q2 2024 Apr 08, 2025	SELL	$8.97 - $12.05 $55,712 - $74,842	-6,211 Reduced 17.61%	29,051 $299,000
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $932 - $1,253	104 Added 0.36%	29,051 $299,000
Q1 2024 May 15, 2024	SELL	$6.21 - $11.05 $10,203 - $18,155	-1,643 Reduced 5.37%	28,947 $307,000
Q4 2023 Feb 13, 2024	SELL	$6.99 - $10.71 $2,768 - $4,241	-396 Reduced 1.28%	30,590 $279,000
Q3 2023 Nov 14, 2023	SELL	$10.26 - $15.7 $62,432 - $95,534	-6,085 Reduced 16.41%	30,986 $321,000
Q2 2023 Aug 21, 2023	BUY	$7.28 - $14.32 $84,018 - $165,267	11,541 Added 45.21%	37,071 $530,000
Q1 2023 May 09, 2023	BUY	$6.19 - $12.36 $2,760 - $5,512	446 Added 1.78%	25,530 $182,000
Q4 2022 Feb 14, 2023	BUY	$9.18 - $11.53 $7,931 - $9,961	864 Added 3.57%	25,084 $281,000
Q3 2022 Nov 18, 2022	SELL	$6.46 - $12.11 $4,586 - $8,598	-710 Reduced 2.85%	24,220 $268,000
Q2 2022 Aug 15, 2022	BUY	$6.2 - $15.5 $26,691 - $66,727	4,305 Added 20.87%	24,930 $210,000
Q1 2022 May 16, 2022	SELL	$11.55 - $20.06 $25,687 - $44,613	-2,224 Reduced 9.73%	20,625 $281,000
Q4 2021 Feb 15, 2022	BUY	$17.83 - $33.15 $6,704 - $12,464	376 Added 1.67%	22,849 $449,000
Q3 2021 Nov 15, 2021	SELL	$30.69 - $36.83 $167,720 - $201,275	-5,465 Reduced 19.56%	22,473 $721,000
Q2 2021 Aug 16, 2021	BUY	$32.66 - $39.87 $342,113 - $417,638	10,475 Added 59.98%	27,938 $946,000
Q1 2021 May 18, 2021	BUY	$33.86 - $48.68 $42,968 - $61,774	1,269 Added 7.84%	17,463 $656,000
Q4 2020 Feb 16, 2021	SELL	$33.22 - $50.26 $14,450 - $21,863	-435 Reduced 2.62%	16,194 $538,000
Q1 2020 May 13, 2020	BUY	$24.65 - $42.83 $4,732 - $8,223	192 Added 1.17%	16,629 $429,000
Q4 2019 Feb 14, 2020	BUY	$18.59 - $37.67 $305,563 - $619,181	16,437 New	16,437 $512,000

Others Institutions Holding PHAT

# of Institutions

152

Shares Held

66.6M

Call Options Held

94K

Put Options Held

55.5K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $358M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account

California State Teachers Retirement System Phathom Pharmaceuticals, Inc. Transaction History